对门诊亲肠道抗微生物治疗方案的抗微生物稳定性测试指南的审查:是时候全球协调测试框架了吗?
Saiyuri Naicker1, Jason A Roberts1,2,3,4, Vesa Cheng1,5,6
1The University of Queensland Centre for Clinical Research, University of Queensland, Brisbane, Queensland, Australia.
JAC-antimicrobial resistance
|December 2, 2024
概括
门诊亲肠道抗微生物疗法 (OPAT) 的抗微生物稳定性测试缺乏全球共识,导致获得不平等的机会. 协调国际指导方针对于一致的治疗计划和服务提供至关重要.
科学领域:
- 制药科学 制药科学
- 传染性疾病 传染性疾病
- 卫生政策 卫生政策
背景情况:
- 抗微生物稳定性对于门诊亲肠道抗微生物疗法 (OPAT) 治疗计划至关重要.
- 目前对稳定性评估的区域法规不一致,造成了对抗微生物药物获取的差异.
研究的目的:
- 对OPAT的抗微生物稳定性测试进行国际监管共识的审查.
- 描述各监管机构对抗微生物药物建议的变化.
主要方法:
- 在OPAT中对抗微生物药物稳定性测试的国际监管准则和标准的文献综述.
- 分析指南的区域差异,特别是温度和特定OPAT指南的区域差异.
主要成果:
- 在抗微生物药物稳定性测试指南中存在显著差异,特别是在温度参数方面.
- 许多地区缺乏针对抗菌素稳定性的具体监管指导或OPAT指导方针.
- 只有英国的NHS提供了关于抗微生物药物稳定性测试的非监管性,OPAT特定的建议.
结论:
- 需要对抗微生物药物稳定性测试进行协调,以建立一个针对OPAT的全球监管框架.
- 解决当前指导方针中已识别的变化领域至关重要.
- 全球框架应整合共识标准,专家意见和药典最佳实践.
更多相关视频
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
3.3K
11:28A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
28.9K
相关概念视频
Antimicrobial Effectiveness
1
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
174
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
174
